The Blood and Marrow Transplant program at OSUCCC - James is internationally recognized for advancements in treating cancer. We have developed a radiation-free preparative regimen for blood and marrow transplantation, now in use throughout the world for treating diseases including chronic myelogenous leukemia.
Each of our physician experts has significant subspecialty experience, including lymphoma, multiple myeloma and leukemia. These transplant leaders offer patients the latest treatment options, many developed through our participation in high-quality, highly relevant clinical trials focused on improving all aspects of transplantation, recovery and quality of life.
Recent findings support our high volume of trials, highlighting the importance of clinical trials in providing consistent transplant methods. We are involved in several National Institutes of Health (NIH)-supported clinical trials, we are one of a select group of transplant centers involved in the NIH-sponsored Blood and Marrow Transplant Clinical Trials Network (BMT CTN), and we are also a main member of the National Cancer Institute (NCI)-sponsored Cancer and Leukemia Group B (CALGB).
More than 2,000 stem cell transplants have been performed at OSUCCC - James, placing us among the most experienced BMT programs in the country. Our work is accredited by the Foundation for the Accreditation of Cellular Therapy, American Association of Blood Banks, Centre for International Blood and Marrow Research, and the National Marrow Donor Program.